New study aims to validate turkish enjoyment scale for active seniors with memory concerns

NCT ID NCT07588685

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study checks if a Turkish version of the Physical Activity Enjoyment Scale (PACES-8) works well for adults aged 65 and older who have mild cognitive impairment. Researchers will ask 100 participants to take a 15-minute walk and then fill out the scale. They will also retest some participants after 15 days to see if the results are consistent. The goal is to provide a reliable way to measure enjoyment of physical activity in this group, which could help promote exercise in older adults.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could provide a reliable tool to measure how much older adults with mild cognitive impairment enjoy physical activity, helping design better exercise programs.
What could go wrong
This is a small, early-stage validation study with only 100 participants, so results may not apply to all older adults. It does not test any treatment or health outcome.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE ABNORMALITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cognitive disorder Cognitive Dysfunction Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Balıkesir University

    Balıkesir, Turkey (Türkiye)

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.